Article

Lower-Intensity Physical Activity Boosts Kidney Function

Objectively assessed light and total physical activities are positively associated with kidney function in patients in the early stages of chronic kidney disease (CKD); objectively or subjectively assessed moderate to vigorous physical activity is not associated significantly.

Objectively assessed light and total physical activities are positively associated with kidney function in patients in the early stages of chronic kidney disease (CKD); objectively or subjectively assessed moderate to vigorous physical activity is not associated significantly. Increased physical activity may slow the progression of CKD by reducing oxidative stress and inflammation, reducing blood pressure, and contributing to weight loss.

Hawkins and coworkers obtained data from the 2003-2004 and 2005-2006 National Health and Nutrition Examination Survey. Patients were asked to wear an accelerometer and were given a physical activity questionnaire. The primary outcome, kidney function, was determined by estimated glomerular filtration rate (eGFR) using a formula based on serum creatinine level, sex, race, and age.

Physical activity generally was related to log eGFR in both women and men. In women, there was a consistent association between light and total physical activity and log eGFR regardless of diabetes mellitus (DM) status. In men, the association was significant only in those who did not have DM.

The authors noted that many professional practice guideline statements of health benefits of physical activity focus on higher-intensity activity, but recently more attention has been paid to activities of lower intensity.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.